[Ophthalmologic control examinations during therapy with ethambutol (author's transl)].
Report on 6,200 control examinations of patients treated with Ethambutol. Subjective troubles of vision do not influence continuation of therapy. In 8 patients (0,5%) symptoms of neuritis nervioptici accompanied with visus deterioration required to stop therapy (case reports on these 8 patients). Ophthalmologic control examinations are recommended before beginning therapy, during continuous therapy in hospital every eight week, and in case of ambulatory intermitting therapy every third to fourth month.
D000368:Aged; D004977:Ethambutol / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D009896:Optic Atrophy / Q000139:chemically induced; D009902:Optic Neuritis / Q000139:chemically induced; D014376:Tuberculosis / Q000188:drug therapy; D014786:Vision Disorders / Q000139:chemically induced*
D004977:Ethambutol
Ophthalmologische Kontrolluntersuchungen während der Therapie mit Ethambutol.